Multinational research teams are invited to apply for ERDERA’s 2026 call focused on providing diagnostic clarity for unsolved rare genetic and nongenetic diseases. The call aims to close these gaps and deliver actionable diagnostic evidence for patients and families. Read more at this LINK.
Open Calls
| Topic | Type of Action | Budget (EUR million) |
Deadline |
ERDERA Clinical Trial Call 2026 (ECTC) |
Multinational Early-Phase Clinical Trials for Rare Diseases (Phase I, I/II and II) | N/A | 10 September 2026 (Mandatory EOI) |
ERDERA Clinical Trial Call 2026 (ECTC) |
Stage 1 Short Proposal Submission | N/A | 15 September – 29 October 2026 |
